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Reutilization of autoclaved intravaginal progesterone device to estrous induction in 
Toggenburg goats 
Reutilização de dispositivos intravaginais de progesterona autoclavados para indução de estro em cabras da 
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Introduction 
Intravaginal devices impregnated with natural or synthetic progesterone are used worldwide for estrous induction 
in sheep and goats. As protocols for estrous induction shortened the time of exposure to progesterone, devices 
were able to be reused until three times to induce estrus (Zambrini et al., 2005). However, despite a good 
cleaning has been employed, there is no total warranty that all microorganisms are eliminated. Thus, sanitary 
risks are associated with devices reutilization. The purpose of this study was to evaluate the effect of autoclaving 
on efficacy of reutilization of intravaginal progesterone devices for estrous induction in Toggenburg goats. 
 
Materials and Methods 
This study was done in October of 2008, in Coronel Pacheco, MG, Brazil. Fourty two Toggenburg nulliparous 
(n=20; 35.2 7.0 kg and 3.5 0.2) and pluriparous (n=22; 50.3 10.2 kg and 3.4 0.3) goats were equally assigned 
according to weigh and body condition score into three treatments. Animals received new devices containing 
0.33g progesterone (Eazi-Breed CIDR®, Pfizer do Brasil Saúde Animal, São Paulo, Brasil; n=17, 41.5 8.5 kg, 
3.4 0.2), autoclaved devices previously used for 6 days (n=13, 43.5 11.0 kg, 3.5 0.3) or 12 days (n=12, 
44.9 16.1 kg, 3.5 0.2). Additionally, 5 mg dinoprost (Lutalyse®, Pfizer do Brasil Saúde Animal) latero-vulvar 
were administered on the day of device insertion, whereas, 200 IU eCG (Novormon 5000®, Sintex Indústria 
Bioquímica, Buenos Aires, Argentina) latero-vulvar 24 h before the device removal. Devices remained for 6 
days period in all treatments. After removal goats were bred twice daily with fertile bucks at estrous onset and 24 
h later if they were still in estrus. Statistical analysis were performed using all tests for statistical significance at 
the 95% confidence interval.  
 
Results and Discussion 
The estrous response and conception rate did not differ (P>0.05) among new device (86.6/60.0%), 6 
(100.0/58.3%), and 12 days (100.0/66.7%) treatments, respectively. Two goats of new device lost their inserts 
and a doe from 6 days got sick; these animals were taken out of the experiment. Interval to estrus was similar 
(P>0.05) for animals of new device (35.1 14.3 h), 6 (33.8 10.4 h) and 12 days (32.0 9.3 h) treatments or 
between nulliparous (33.5 11.0 h) and pluriparous (32.7 11.2 h) goats. The estrous duration was the same 
(P>0.05) in all treatments (32.3 9.0 h; 32.0 10.7 h; 32 9.4 h, for new devices, 6 and 12 days treatments, 
respectively) and for nulliparous (27.5 12.6 h) or pluriparous (28.0 10.1 h). All treatments were efficient to 
induce estrus in Toggenburg goats in nonbreeding season. The autoclaving process did not affect the efficiency 
of reutilizing intravaginal progesterone devices for Toggenburg goats. This technique can be a simple and 
valuable tool to reduce sanitary risks of disease transmission without alterating fertility in goats. 
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